Jacob E.
Jacob E. Kiragu, Palm Beach, FL US
Patent application number | Description | Published |
---|---|---|
20140119864 | Portable Vehicle Lift and Repair System - A vehicle lift and repair system includes a flatbed trailer provided with a wood-like or separate metallic surface upon a base of the trailer, the surface having recesses, and weight bearing axles beneath in a region of the recesses. Included is a hydraulic lift having a base support positioned within the recesses in the surface of the trailer, the recesses having a depth sufficient to include all components of the lift, including a top thereof substantially flush with the surface when the lift is retracted. The lift is preferably positioned in relation to a transverse mid-line between the weight-bearing axles. Ramps facilitate positioning on the lift of an auto-to-be-repaired. A generator, compressor and hydraulic fluid reservoir for the hydraulic vehicle lift are situated toward a front of the trailer. | 05-01-2014 |
Jacob E. Koskimaki, Baltimore, MD US
Patent application number | Description | Published |
---|---|---|
20130316950 | MIMETIC PEPTIDES DERIVED FROM COLLAGEN TYPE IV AND THEIR USE FOR TREATING ANGIOGENESIS- AND LYMPHAGIOGENESIS-DEPENDENT DISEASES - Mimetic peptides having anti-angiogenic and anti-tumorigenic properties and methods of their use for treating cancer, ocular diseases, such as age-related macular degeneration, and other-angiogenesis-dependent diseases are disclosed. More particularly, active non-cysteine analogs (mimetics), which exhibit anti-angiogenic activity in endothelial cell proliferation, migration, adhesion, and tube formation assays, anti-migratory activity in human breast cancer cells in vitro, anti-angiogenic and anti-tumorigenic activity in vivo in breast cancer xenograft models, and age-related macular degeneration models are disclosed. The presently disclosed mimetic peptides also exhibit anti-lymphangiogenic and directly anti-tumorigenic properties. | 11-28-2013 |
Jacob E. Pananen, Pasadena, CA US
Patent application number | Description | Published |
---|---|---|
20100305551 | Valveless Impedance Pump Drug Delivery Systems - A drug-delivery unit suitable for implantation into a patient body may include a valveless impedance pump. In some implementations the unit may include an actuator, control electronics and a battery, and may communicate with an external patient interface unit. The patient interface unit can be used to control operation of the implant and to download data from the implant. The patient interface unit can also be used to charge the implant and/or a separate charger can be used. In other implementations, a drug-delivery implant unit may lack internal electronics and instead rely on an externally-supplied magnetic field to actuate the pump. | 12-02-2010 |
20110071493 | Flow-Induced Delivery from a Drug Mass - Drug solutions (or other combinations of vehicle with entrained drug) are prepared by removing drug from one or more masses of a solid form of the drug. The solid form of the drug may be sparingly soluble or insoluble in water. Examples of devices for holding solid drug and facilitating delivery of such drug to targeted regions are also described. | 03-24-2011 |
Jacob E. Pananen, Los Angeles, CA US
Patent application number | Description | Published |
---|---|---|
20090209945 | VALVELESS IMPEDANCE PUMP DRUG DELIVERY SYSTEMS - A drug-delivery unit suitable for implantation into a patient body may include a valveless impedance pump. In some implementations the unit may include an actuator, control electronics and a battery, and may communicate with an external patient interface unit. The patient interface unit can be used to control operation of the implant and to download data from the implant. The patient interface unit can also be used to charge the implant and/or a separate charger can be used. In other implementations, a drug-delivery implant unit may lack internal electronics and instead rely on an externally-supplied magnetic field to actuate the pump. | 08-20-2009 |
20110136870 | GACYCLIDINE FORMULATIONS - Improved formulations of gacyclidine for direct administration to the inner or middle ear. | 06-09-2011 |
20120208848 | GACYCLIDINE FORMULATIONS - Improved formulations of gacyclidine for direct administration to the inner or middle ear. | 08-16-2012 |
Jacob E. Pechenik, New York, NY US
Patent application number | Description | Published |
---|---|---|
20110276368 | METHOD AND SYSTEM FOR COLLECTING AND USING MARKET DATA FROM VARIOUS SOURCES - A system and a method for collecting and using market data. The system includes a workstation, where at least one message is entered, a transmitter, where the at least one message is transmitted, a parser for parsing the at least one message, a data recognizer for identifying relevant information in the at least one message, a processor for extracting the relevant information and a communicator for communicating the relevant information. | 11-10-2011 |
20110276516 | METHOD AND SYSTEM FOR COLLECTING AND USING MARKET DATA FROM VARIOUS SOURCES - A system and a method for collecting and using market data. The system includes a workstation, where at least one message is entered, a transmitter, where the at least one message is transmitted, a parser for parsing the at least one message, a data recognizer for identifying relevant information in the at least one message, a processor for extracting the relevant information and a communicator for communicating the relevant information. | 11-10-2011 |
20130166433 | METHOD AND SYSTEM FOR COLLECTING AND PARSING MARKET DATA FROM VARIOUS SOURCES - A system comprises at least one computer device in communication with one or more server computers. The system converts unstructured text into usable order details, and uses instant messaging to notify recipients of the order details. The notices include electronic web links that launch a web interface that generates an editable, pre-populated electronic order ticket based on the order details. Submission of the electronic order ticket launches an auction during which the recipients may respond with offers to fulfill to the electronic order ticket. If after the auction more than one response is needed to fill the electronic order ticket, the system automatically allocates how and in which order the responses will be used to fill the electronic order ticket. If the electronic order ticket is not completely filled after the auction, the electronic order ticket is submitted to one or more additional exchanges for further filling. | 06-27-2013 |
Jacob E. Shaffer, Jr., Phoenix, AZ US
Patent application number | Description | Published |
---|---|---|
20100141210 | ALTERNATOR FOR CHARGING MULTIPLE ELECTRIC STORAGE DEVICES - An alternator includes a body portion housing a charging circuit. A voltage regulator is mounted to the body portion and electrically coupled to the charging circuit. The voltage regulator is configured and disposed to output at least one charging current. An isolator is mounted to the body portion and electrically coupled to the charging circuit and the voltage regulator. The isolator is configured and disposed to be electrically coupled to at least two batteries with the isolator independently passing the at least one charging current to each of the first and second batteries. | 06-10-2010 |
Jacob E. Shokes, Winston-Salem, NC US
Patent application number | Description | Published |
---|---|---|
20150030657 | SMOOTH MUSCLE CELL CONSTRUCTS - The present invention relates to the regeneration, reconstruction, augmentation or replacement of luminal organs or tissue structures in a subject in need using scaffolds seeded with autologous or non-autologous cell populations that are or are not derived from the corresponding organ or tissue structure that is the subject of the regeneration, reconstruction, augmentation or replacement. | 01-29-2015 |
Jacob E. Yackenovich, Morrisville, NC US
Patent application number | Description | Published |
---|---|---|
20140325071 | AUTONOMIC SLA BREACH VALUE ESTIMATION - A method, system and apparatus for estimating an SLA breach value. The method can include processing resource data to identify an acceptable SLA breach value; and, displaying the acceptable SLA breach value through a user interface. The processing step can include identifying a best practices SLA breach value based upon resource data for an aggregation of customers. Alternatively, the processing step can include identifying an average SLA breach value for a specific customer. As a further alternative, the identifying step can include identifying an average SLA breach value for a specific customer for a specific resource. As yet a further alternative, the processing step can include identifying an SLA breach value trend based upon past measured historical systems management data; and, predicting a future SLA breach value based upon the trend. In all cases, the acceptable SLA breach value can be increased by a fixed proportion. | 10-30-2014 |